Skip to content

Intrathecal Dexamethasone and Atropine on Morphine Induced Post-operative Nausea and Vomiting on Caesarean Section

Prophylactic Efficacy and Safety of Intrathecal Dexamethasone, Atropine or Their Combination on Morphine Induced Post-operative Nausea and Vomiting on Patients Undergoing Caesarean Section With Spinal Anaesthesia

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05560542
Enrollment
150
Registered
2022-09-29
Start date
2022-10-01
Completion date
2025-10-01
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morphine Adverse Reaction

Brief summary

Pain is a major problem during the postoperative period and can be considered as a challenge for the anesthesiologist. Low dose intrathecal morphine is proven efficient as a mode to reduce postoperative pain. Morphine has many complications like post-operative nausea and vomiting (PONV). the investigators will investigate the utility of intrathecal (IT) atropine and dexamethasone for prevention of morphine induced PONV as a primary outcome in parturient undergoing CS under spinal bupivacaine anesthesia plus morphine sulfate as an adjuvant.

Detailed description

Pain is a major problem during the postoperative period and can be considered as a challenge for the anesthesiologist. Low dose intrathecal morphine is proven efficient as a mode to reduce postoperative pain in many surgical areas including Caesarean delivery. Morphine has many complications namely pruritus, and post-operative nausea and vomiting (PONV). The other risk factors for the development of PONV include female gender, non-smoker status, general anesthesia with inhalational anesthetics and surgical factors (duration and type of surgery). The supplementation of morphine, however raises the occurrences of postoperative nausea and vomiting (PONV) in these patient To tackle this problem, the investigators have to use the combination therapy of antiemetics like a serotonin receptor antagonist of either intravenous (IV) ondansetron or granisetron with IV dexamethasone is administered after the administration of intrathecal morphine. Dopamine receptor antagonists e.g. droperidol and metoclopramide are commonly used, but they carry the risk of extrapyramidal symptoms.

Interventions

DRUGAtropine and Dexamethasone

Intrathecal dexamethasone, atropine or their combination.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Female 2. 18-45 years old 3. ASA: 1, 2 4. Elective caesarean section under spinal anaesthesia.

Exclusion criteria

1. Patient refusal. 2. Contraindications to spinal anaesthesia as coagulopathy, infection at site of injection, hemodynamic instability and uncooperative patient. 3. Contraindications to administration of morphine as asthmatic patient and hypersensitivity and contraindications to any of the study drugs. 4. Adult-Emergency CS as there is no time for preparation and risk on fetus and mother for time consuming

Design outcomes

Primary

MeasureTime frameDescription
Incidence and severity of PONV24 hourIncidence and severity of PONV by designing questionnaire and specific scale: 1. no nausea or vomiting 2. mild nausea and vomiting but no need to treatment 3. moderate nausea and vomiting that need treatment 4. severe form of nausea and vomiting and resistant to treatment

Secondary

MeasureTime frameDescription
Antiemetic24 hourTotal dose of post-operative rescue antiemetic (ondansetron in mg) for 24 hour
Post-operative pain profile24 hourPost-operative visual analog scale (1: no pain and 10: the most severe experienced pain ) for 24 hour.
Incidence of Side Effects24 hourAnticipated side effects as shivering and hypotension( number of patients and severity)
Analgesia24 hourTime to the first post-operative rescue analgesic for 24 hour.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026